Delivery Order SPE2DB22D1200-SPE2DB25FN2EM

Award Date 5/28/25
Potential Completion Date 6/18/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of IMBRUVICA 420 MG TABLET 28S. The award, valued at $7,575.75, is a firm fixed-price contract with a completion date of December 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
This federal contract award, valued at $7,575.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imbruvica 420 mg tablets, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. No set-aside designation was used. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.76, is for the delivery of Imbruvica 140mg medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm fixed-price delivery order contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,932.55 contract is for the supply of 4,568,186,072 units of the medication IMBRUVICA 420 MG TABLET 28S. The delivery order has a performance period through May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that allows the company to supply...
This is a $33,865.10 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,188,793 units of the drug Imbruvica 420 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $7,322.67, is for the delivery of IMBRUVICA 420 MG tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, with a...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN2EM
    Delivery Order

This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,575.75 firm-fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a medication. The contract has a period of performance through June 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents an open competition award to the vendor. The contract supports medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/27/25, 9:43 AM